Hwa Kwo Yen

Title: Hwa Kwo Yen: Innovator in Pharmaceutical Development

Introduction

Hwa Kwo Yen is a notable inventor based in Malvern, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target cell proliferative disorders. With a total of 2 patents, his work has the potential to impact the treatment of various medical conditions.

Latest Patents

Hwa Kwo Yen's latest patents focus on N-substituted tricyclic 3-aminopyrazole derivatives. These compounds serve as inhibitors for the platelet-derived growth factor receptor (PDGF-R) kinase. The inventions are directed towards pharmaceutical compositions that can be used to treat tumors and other cell proliferative disorders. The methods for preparing these derivatives are also outlined in his patents, showcasing the innovative approaches he has developed.

Career Highlights

Hwa Kwo Yen is currently associated with Janssen Pharmaceutica NV, where he continues to advance his research and development efforts. His work in the pharmaceutical industry has positioned him as a key player in the innovation of therapeutic solutions.

Collaborations

Some of Hwa Kwo Yen's notable coworkers include Chih Yung Ho and Bengt Anders Brunmark. Their collaborative efforts contribute to the ongoing advancements in the field of pharmaceuticals.

Conclusion

Hwa Kwo Yen's contributions to pharmaceutical innovations, particularly in the area of cell proliferative disorders, highlight his role as a significant inventor. His patents reflect a commitment to improving treatment options for patients, showcasing the importance of innovation in healthcare.